SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Lysergic Acid Diethylamide–Assisted Therapy in Patients With Anxiety With and Without a Life-Threatening Illness: A Randomized, Double-Blind, Placebo-Controlled Phase II Study
13 references·11 citing·34 second hop
Lysergic Acid Diethylamide–Assisted Therapy in Patients With Anxiety With and Without a Life-Threatening Illness: A Randomized, Double-Blind, Placebo-Controlled Phase II Study (2022)Lysergic Acid Diethylamide–Assisted Thera…Trial of Psilocybin versus Escitalopram for Depression (2021)Trial of Psilocybin versus Es…Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder (2020)Effects of Psilocybin-Assiste…Quality of Acute Psychedelic Experience Predicts Therapeutic Efficacy of Psilocybin for Treatment-Resistant Depression (2018)Quality of Acute Psychedelic …The Fabric of Meaning and Subjective Effects in LSD-Induced States Depend on Serotonin 2A Receptor Activation (2017)The Fabric of Meaning and Sub…Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial (2016)Rapid and sustained symptom r…Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study (2016)Psilocybin with psychological…Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial (2016)Psilocybin produces substanti…Epidemiology of anxiety disorders in the 21st century (2015)Epidemiology of anxiety disor…Safety and Efficacy of Lysergic Acid Diethylamide-Assisted Psychotherapy for Anxiety Associated With Life-threatening Diseases (2014)Safety and Efficacy of Lyserg…LSD-assisted psychotherapy for anxiety associated with a life-threatening disease: A qualitative study of acute and sustained subjective effects (2014)LSD-assisted psychotherapy fo…Acute Effects of Lysergic Acid Diethylamide in Healthy Subjects (2014)Acute Effects of Lysergic Aci…Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer (2010)Pilot Study of Psilocybin Tre…Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action (1998)Psilocybin induces schizophre…Single Treatment With MM120 (Lysergide) in Generalized Anxiety Disorder (2025)Single Treatment With MM120 (…The Psychedelic Future of Post-Traumatic Stress Disorder Treatment (2024)The Psychedelic Future of Pos…Expectancy Effects in Psychedelic Trials (2024)Expectancy Effects in Psyched…Efficacy and safety of psychedelics for the treatment of mental disorders: A systematic review and meta-analysis (2024)Efficacy and safety of psyche…Adverse Events in Studies of Classic Psychedelics (2024)Adverse Events in Studies of …Psychedelic Commercialization: A Wide-Spanning Overview of the Emerging Psychedelic Industry (2023)Psychedelic Commercialization…Pharmacological Treatment of Generalised Anxiety Disorder: Current Practice and Future Directions (2023)Pharmacological Treatment of …Investigation of self-treatment with lysergic acid diethylamide and psilocybin mushrooms: Findings from the Global Drug Survey 2020 (2023)Investigation of self-treatme…Drug–drug interactions involving classic psychedelics: A systematic review (2023)Drug–drug interactions involv…Comparative acute effects of mescaline, lysergic acid diethylamide, and psilocybin in a randomized, double-blind, placebo-controlled cross-over study in healthy participants (2023)Comparative acute effects of …A neurophenomenological approach to non-ordinary states of consciousness: hypnosis, meditation, and psychedelics (2022)A neurophenomenological appro…The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10 (1998)Lifetime Prevalence and Age-of-Onset Distributions of DSM-IV Disorders in the National Comorbidity Survey Replication (2005)Diagnostic and Statistical Manual of Mental Disorders (2013)Treatment of anxiety disorders (2017)Life Expectancy and Mortality Rates in the United States, 1959-2017 (2019)Handbook of Religion and Health (2023)Manual for the State-Trait Anxiety Inventory (1970)Hallucinogens (2004)Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance (2006)Psilocybin for treatment-resistant depression: fMRI-measured brain mechanisms (2017)The Therapeutic Potential of Psychedelic Drugs: Past, Present, and Future (2017)Psychedelics and Psychedelic-Assisted Psychotherapy (2020)An Inventory for Measuring Depression (1961)The Brief Psychiatric Rating Scale (1962)Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin (2012)Diagnostic and Statistical Manual of Mental Disorders (2013)Psychedelics Promote Structural and Functional Neural Plasticity (2018)REBUS and the Anarchic Brain: Toward a Unified Model of the Brain Action of Psychedelics (2019)The Hospital Anxiety and Depression Scale (1983)Optimism, coping, and health: Assessment and implications of generalized outcome expectancies. (1985)Psychedelics (2016)The varieties of religious experience: A study in human nature. (1902)Tests for comparing elements of a correlation matrix. (1980)Psychedelics and the essential importance of context (2018)Psychedelic drugs: neurobiology and potential for treatment of psychiatric disorders (2020)Percentage of Heavy Drinking Days Following Psilocybin-Assisted Psychotherapy vs Placebo in the Treatment of Adult Patients With Alcohol Use Disorder (2022)A RATING SCALE FOR DEPRESSION (1960)The Columbia–Suicide Severity Rating Scale: Initial Validity and Internal Consistency Findings From Three Multisite Studies With Adolescents and Adults (2011)Psilocybin induces rapid and persistent growth of dendritic spines in frontal cortex in vivo (2021)Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression (2022)Hallucinogens Recruit Specific Cortical 5-HT2A Receptor-Mediated Signaling Pathways to Affect Behavior (2007)Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later (2008)Psilocybin with psychological support for treatment-resistant depression: six-month follow-up (2017)Single-Dose Psilocybin Treatment for Major Depressive Disorder (2023)
this work references cited by second hop

References

  • 2016Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial2,196 cited
  • 2015Epidemiology of anxiety disorders in the 21st century2,077 cited
  • 2016Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial1,696 cited
  • 2016Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study1,533 cited
  • 2021Trial of Psilocybin versus Escitalopram for Depression1,386 cited
  • 2020Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder1,296 cited
  • 2010Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer1,205 cited
  • 1998Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action1,015 cited
  • 2018Quality of Acute Psychedelic Experience Predicts Therapeutic Efficacy of Psilocybin for Treatment-Resistant Depression806 cited
  • 2014Safety and Efficacy of Lysergic Acid Diethylamide-Assisted Psychotherapy for Anxiety Associated With Life-threatening Diseases749 cited
  • 2014LSD-assisted psychotherapy for anxiety associated with a life-threatening disease: A qualitative study of acute and sustained subjective effects454 cited
  • 2014Acute Effects of Lysergic Acid Diethylamide in Healthy Subjects411 cited
  • 2017The Fabric of Meaning and Subjective Effects in LSD-Induced States Depend on Serotonin 2A Receptor Activation

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

400 cited

Cited by

  • 2024Adverse Events in Studies of Classic Psychedelics156 cited
  • 2022A neurophenomenological approach to non-ordinary states of consciousness: hypnosis, meditation, and psychedelics150 cited
  • 2024Efficacy and safety of psychedelics for the treatment of mental disorders: A systematic review and meta-analysis145 cited
  • 2023Comparative acute effects of mescaline, lysergic acid diethylamide, and psilocybin in a randomized, double-blind, placebo-controlled cross-over study in healthy participants129 cited
  • 2024The Psychedelic Future of Post-Traumatic Stress Disorder Treatment80 cited
  • 2024Expectancy Effects in Psychedelic Trials73 cited
  • 2023Drug–drug interactions involving classic psychedelics: A systematic review69 cited
  • 2023Pharmacological Treatment of Generalised Anxiety Disorder: Current Practice and Future Directions67 cited
  • 2023Psychedelic Commercialization: A Wide-Spanning Overview of the Emerging Psychedelic Industry63 cited
  • 2023Investigation of self-treatment with lysergic acid diethylamide and psilocybin mushrooms: Findings from the Global Drug Survey 202060 cited
  • 2025Single Treatment With MM120 (Lysergide) in Generalized Anxiety Disorder44 cited